Quoin Pharmaceuticals Ltd... (QNRX)
0.57
-0.00 (-0.28%)
At close: Jan 14, 2025, 3:58 PM
0.57
-0.11%
After-hours Jan 14, 2025, 06:40 PM EST
undefined% (undefined)
| Bid | 0.56 |
| Market Cap | 3.13M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -3.66 |
| PE Ratio (ttm) | -0.16 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.62 |
| Volume | 211,645 |
| Avg. Volume (20D) | 3,486,680 |
| Open | 0.61 |
| Previous Close | 0.57 |
| Day's Range | 0.57 - 0.61 |
| 52-Week Range | 0.42 - 6.18 |
| Beta | undefined |
About QNRX
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia....
Industry Biotechnology
Sector Healthcare
IPO Date Aug 1, 2016
Employees 4
Stock Exchange NASDAQ
Ticker Symbol QNRX
Website https://quoinpharma.com
Analyst Forecast
According to 1 analyst ratings, the average rating for QNRX stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 601.02% from the latest price.
Buy 100.00%
Hold 0.00%
Sell 0.00%
3 weeks ago ·
Source
+14.99%
Quoin Pharmaceuticals shares are trading higher af...
Unlock content with
Pro Subscription
10 months ago ·
Source
-48.28%
Quoin Pharmaceuticals shares are trading lower after the company announced the pricing of a $6.5 million public offering.
